AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Hosted on MSN7d
AbbVie Just Paid Investors: Here’s How Much They ReceivedAbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb.
So, it's important to know a company's potential revenue growth. For AbbVie, the consensus sales estimate for the current quarter of $12.96 billion indicates a year-over-year change of +5.3%.
one can better assess the future performance of a company Every investor in AbbVie Inc. (NYSE:ABBV) should be aware of the most powerful shareholder groups. The group holding the most number of ...
AbbVie Inc discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma ...
During the episode, Cramer noted AbbVie Inc.’s (NYSE:ABBV) success and called it a buy. “Oh, AbbVie is just a gem and… They bought a company that with something, it failed and no one even ...
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Jim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback